Caitong International Asset Management’s Genmab GMAB Stock Holding History

Caitong International Asset Management’s Portfolio GMAB Stock Details GMAB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$280K	Buy	+10,203	New	+$271K	0.04%	352
2026 Q1	–	Sell	-2,725	Closed	-$83.9K	–	2768
2025 Q4	$83.9K	Sell	2,725 -4,447	-62%	-$139K	0.02%	503
2025 Q3	$220K	Buy	7,172 +1,363	+23%	+$33.2K	0.15%	71
2025 Q2	$120K	Buy	5,809 +3,878	+201%	+$79.6K	0.09%	131
2025 Q1	$37.8K	Buy	1,931 +1,070	+124%	+$22.4K	0.03%	586
2024 Q4	$18K	Buy	+861	New	+$18.9K	0.02%	820

Other funds holding GMAB

PBA

Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return

OAG

Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Sofinnova Investments Menlo Park, California $1.93B AUM 134.74% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Caitong International Asset Management's GMAB Position: Q2 2026 in Review

Caitong International Asset Management opened a new position in Genmab (GMAB) in Q2 2026: 10,203 shares worth $280K. The stake represents 0.04% of the portfolio and ranks #352 among its holdings. This is a return to the name: Caitong International Asset Management previously reported a position in GMAB as recently as Q4 2025.

Caitong International Asset Management first reported a position in GMAB in Q4 2024 and has held it in 6 quarters since. 289 funds tracked by Wall St. Rank hold GMAB as of Q2 2026.

Caitong International Asset Management held 10,203 shares of Genmab worth $280K as of Q2 2026.
Genmab was a new Caitong International Asset Management position in Q2 2026.
Genmab made up 0.04% of Caitong International Asset Management's portfolio in Q2 2026, its #352 holding.
Caitong International Asset Management first reported a position in Genmab in Q4 2024 and has held it in 6 quarters since.
289 funds tracked by Wall St. Rank held Genmab as of Q2 2026.

Based on Caitong International Asset Management's 13F filing for Q2 2026, filed 5 Aug 2026.